Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib

Objectives: To compare the efficacy and safety of lumiracoxib with placebo and celecoxib for osteoarthritis OA in a 13 week, multicentre, randomised, double blind study. Methods: After a 37 day washout period for nonsteroidal antiinflammatory drugs, 1702 patients with knee OA were randomised to lumi...

Full description

Saved in:
Bibliographic Details
Main Authors: Tannenbaum, H, Berenbaum, F, Reginster, J, Zacher, J, Robinson, J, Poor, G, Bliddal, H, Uebelhart, D, Adami, S, Navarro, F, Lee, A, Moore, A, Gimona, A
Format: Artigo
Language:Inglês
Published: 2004
Subjects:
Extended Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1754793/
https://ncbi.nlm.nih.gov/pubmed/15020310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2003.015974
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items